October 2013

FDA Requires Stronger Peripheral Neuropathy Warning for Quinolones

The Food and Drug Administration is requiring a stronger warning about the potential for peripheral neuropathy with fluoroquinolone antibiotics that are taken orally or by injection. The warning does not apply to topical formulations, which have not been associated with neuropathy. Drug labels and patient medication guides must be updated, said the agency.  READ MORE …

FDA Requires Stronger Peripheral Neuropathy Warning for Quinolones Read More »

UB Study to Identify Molecular Process Leading to Peripheral Pain

A faculty member in the UB medical school has received a $1.2 million federal grant to study the gating mechanism of a temperature-sensitive ion channel protein found abundantly in peripheral nerve endings. The research by Feng Qin, associate professor of physiology and biophysics, on the vanilloid receptor TRPV1 could lead to new drugs that target …

UB Study to Identify Molecular Process Leading to Peripheral Pain Read More »